Refresh

Mankind Pharma Ltd. - Research Center

543904 MANKIND Group (B) BSE data
Back to Company

Results

Statement

More

Half Yearly results in brief
(Rs crore)
Sep ' 23 Sep ' 22

Sales

4,753.56 4,318.80

Operating profit

1,174.66 942.72

Interest

6.28 17.62

Gross profit

1,283.94 1,013.03

EPS (Rs)

22.02 17.93
Half yearly  results in details
Sep ' 23 Sep ' 22

Other income

115.55 87.92

Stock adjustment

17.83 218.14

Raw material

443.38 385.72

Power and fuel

- -

Employee expenses

981.49 849.83

Excise

- -

Admin and selling expenses

- -

Research and development expenses

- -

Expenses capitalised

- -

Other expenses

2,136.19 1,922.39

Provisions made

- -

Depreciation

145.58 131.26

Taxation

256.19 163.37

Net profit / loss

882.17 718.40

Extra ordinary item

- -

Prior year adjustments

- -

Equity capital

40.06 40.06

Equity dividend rate

- -

Agg.of non-prom. shares (Lacs)

- -

Agg.of non promotoholding (%)

- -

OPM (%)

24.71 21.83

GPM (%)

26.37 22.99

NPM (%)

18.12 16.30
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com